261 related articles for article (PubMed ID: 17197171)
21. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
22. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
23. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway.
Li H; Huang J; Yang B; Xiang T; Yin X; Peng W; Cheng W; Wan J; Luo F; Li H; Ren G
Toxicol Appl Pharmacol; 2013 Oct; 272(1):180-90. PubMed ID: 23707762
[TBL] [Abstract][Full Text] [Related]
24. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
[TBL] [Abstract][Full Text] [Related]
26. [The role of transcription factor Snail1 in the regulation of hormonal sensitivity of in vitro cultured breast cancer cells].
Andreeva OE; Shcherbakov AM; Shatskaia VA; Krasil'nikov MA
Vopr Onkol; 2012; 58(1):71-6. PubMed ID: 22629832
[TBL] [Abstract][Full Text] [Related]
27. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
28. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS
J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661
[TBL] [Abstract][Full Text] [Related]
29. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
[TBL] [Abstract][Full Text] [Related]
30. Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
Gökmen-Polar Y; Toroni RA; Hocevar BA; Badve S; Zhao Q; Shen C; Bruckheimer E; Kinch MS; Miller KD
Breast Cancer Res Treat; 2011 Jun; 127(2):375-84. PubMed ID: 20602165
[TBL] [Abstract][Full Text] [Related]
31. Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells.
Borley AC; Hiscox S; Gee J; Smith C; Shaw V; Barrett-Lee P; Nicholson RI
Breast Cancer Res; 2008; 10(6):R103. PubMed ID: 19055788
[TBL] [Abstract][Full Text] [Related]
32. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells.
Nagaharu K; Zhang X; Yoshida T; Katoh D; Hanamura N; Kozuka Y; Ogawa T; Shiraishi T; Imanaka-Yoshida K
Am J Pathol; 2011 Feb; 178(2):754-63. PubMed ID: 21281808
[TBL] [Abstract][Full Text] [Related]
33. Fibroblasts induce epithelial to mesenchymal transition in breast tumor cells which is prevented by fibroblasts treatment with histamine in high concentration.
Porretti JC; Mohamad NA; Martín GA; Cricco GP
Int J Biochem Cell Biol; 2014 Jun; 51():29-38. PubMed ID: 24685678
[TBL] [Abstract][Full Text] [Related]
34. Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement.
Dinicola S; Fabrizi G; Masiello MG; Proietti S; Palombo A; Minini M; Harrath AH; Alwasel SH; Ricci G; Catizone A; Cucina A; Bizzarri M
Exp Cell Res; 2016 Jul; 345(1):37-50. PubMed ID: 27237097
[TBL] [Abstract][Full Text] [Related]
35. Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells.
He Q; Gong Y; Gower L; Yang X; Friesel RE
J Cell Biochem; 2016 Oct; 117(10):2346-56. PubMed ID: 26950413
[TBL] [Abstract][Full Text] [Related]
36. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
[TBL] [Abstract][Full Text] [Related]
37. Membrane-initiated estradiol signaling of epithelial-mesenchymal transition-associated mechanisms through regulation of tight junctions in human breast cancer cells.
Jiménez-Salazar JE; Posadas-Rodríguez P; Lazzarini-Lechuga RC; Luna-López A; Zentella-Dehesa A; Gómez-Quiroz LE; Königsberg M; Domínguez-Gómez G; Damián-Matsumura P
Horm Cancer; 2014 Jun; 5(3):161-73. PubMed ID: 24771004
[TBL] [Abstract][Full Text] [Related]
38. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
Arima Y; Inoue Y; Shibata T; Hayashi H; Nagano O; Saya H; Taya Y
Cancer Res; 2008 Jul; 68(13):5104-12. PubMed ID: 18593909
[TBL] [Abstract][Full Text] [Related]
39. Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation.
Aokage K; Ishii G; Ohtaki Y; Yamaguchi Y; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
Int J Cancer; 2011 Apr; 128(7):1585-95. PubMed ID: 20533280
[TBL] [Abstract][Full Text] [Related]
40. Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack.
Scherbakov AM; Stefanova LB; Sorokin DV; Semina SE; Berstein LM; Krasil'nikov MA
Exp Cell Res; 2013 Dec; 319(20):3150-9. PubMed ID: 23973669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
